These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6760680)

  • 1. Peripheral vasodilatation in the treatment of hypertension. Prazosin compared with hydralazine in patients not responding to beta-receptor blockade.
    Malmberg L; Fagerberg SE; Frithz G
    Acta Med Scand Suppl; 1982; 665():121-4. PubMed ID: 6760680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.
    Hua AS; Macdonald IM; Myers JB; Fang P; Kincaid-Smith P
    Med J Aust; 1977 Jul; 2(1):5-9. PubMed ID: 331040
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of prazosin with hydralazine in patients receiving hydrochlorothiazide. A randomized, double-blind clinical trial.
    Circulation; 1981 Oct; 64(4):772-9. PubMed ID: 7023744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].
    Melkild A
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):148-49. PubMed ID: 6992338
    [No Abstract]   [Full Text] [Related]  

  • 5. A cross-over study between hydrallazine and prazosin.
    Rasmussen K; Jensen HA
    Clin Sci Mol Med Suppl; 1976 Dec; 3():621s-623s. PubMed ID: 799569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of prazosin to standard triple therapy in the treatment of severe hypertension.
    Heagerty AM; Russell GI; Bing RF; Thurston H; Swales JD
    Br J Clin Pharmacol; 1982 Apr; 13(4):539-41. PubMed ID: 7066169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies with prazosin--a new effective hypotensive agent. III. An acute double-blind cross-over study comparing the effects of single doses of prazosin and hydrallazine in combination with propranolol and a diuretic.
    Hua AS; Myers JB; Kincaid-Smith P
    Med J Aust; 1978 Jan; 1(1):45-8. PubMed ID: 368538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral vasodilators in the treatment of hypertension. A review].
    Rasmussen K
    Ugeskr Laeger; 1979 Jan; 141(5):312-4. PubMed ID: 760314
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypotensive effect and tolerability of a short course of treatment with prazosin (pratsiol) and hydralazine (apressin) in a cooperative study of new drugs for the prevention of arterial hypertension].
    Kardiologiia; 1985 Jan; 25(1):23-8. PubMed ID: 3981857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
    Marshall AJ; Barritt DW; Pocock J; Heaton ST
    Lancet; 1977 Feb; 1(8006):271-4. PubMed ID: 64803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind cross-over comparison of hydralazine and prazosin in hypertensive subjects on a beta-adrenoceptor blocking agent (atenolol).
    Jones JV; Steiner JM
    Br J Clin Pharmacol; 1980 Nov; 10(5):531-3. PubMed ID: 7437268
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R
    Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilators in the treatment of hypertension.
    Kincaid-Smith P
    Med J Aust; 1975 Jan; 1(SP2):7-9. PubMed ID: 235714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate.
    Adigun AQ; Ajayi OE; Sofowora GG; Ajayi AA
    Int J Cardiol; 1998 Nov; 67(1):81-6. PubMed ID: 9880204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
    Whelton PK; Russell RP; Sova-Schulz K; Wyndham R; Walker WG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S28-37. PubMed ID: 94637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of blood pressure, plasma lipid and cardiac performance responses to prazosin versus propranolol in thiazide-treated hypertensive patients.
    Misson R; Merkel T; Cutler RE
    Am J Cardiol; 1984 Jan; 53(3):51A-54A. PubMed ID: 6364760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotensive agents. Part I: Vasodilators.
    Romankiewicz JA
    J Pract Nurs; 1979 Jun; 29(6):10-2. PubMed ID: 255614
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasodilator monotherapy in the treatment of hypertension: comparative efficacy and safety of pinacidil, a potassium channel opener, and prazosin.
    Goldberg MR; Sushak CS; Rockhold FW; Thompson WL
    Clin Pharmacol Ther; 1988 Jul; 44(1):78-92. PubMed ID: 3292105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker.
    Ramsay LE; Parnell L; Waller PC
    Postgrad Med J; 1987 Feb; 63(736):99-103. PubMed ID: 3671250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans.
    Leenen FH; Smith DL; Farkas RM; Reeves RA; Marquez-Julio A
    Am J Med; 1987 May; 82(5):969-78. PubMed ID: 2953239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.